Bacterial imaging in tumour diagnosis

Area of Science:

• Oncology
• Microbiology
• Biotechnology
• Medical Imaging

Background:

• Certain bacteria, such as Escherichia coli (E. coli) and Salmonella typhimurium (S. typhimurium), possess an innate tropism for solid tumors.
• These bacteria serve as a versatile platform for enhancing tumor diagnosis and treatment strategies in oncology.

Purpose of the Study:

• To explore the application of bacterial imaging in tumor diagnosis, offering dynamic, real-time monitoring for pre-treatment assessment and post-treatment surveillance.
• To review various imaging modalities and their utility in observing and tracking tumor-associated bacteria.

Main Methods:

• Utilized optical imaging (bioluminescence, fluorescence), acoustic imaging, magnetic resonance imaging (MRI), and nuclear medicine imaging (PET, SPECT) to visualize and track bacteria.
• Discussed strategies involving synthetic biology and nanomaterial engineering to improve bacterial viability and tumor localization.
• Addressed challenges including low bacterial abundance, heterogeneous distribution, high-dimensional data, and imaging limitations.

Main Results:

• Optical imaging offers high sensitivity and resolution.
• Acoustic imaging provides real-time, non-invasive visualization with good penetration.
• MRI delivers high spatial resolution without radiation.
• Nuclear medicine imaging (PET, SPECT) elucidates bacterial distribution and dynamics.

Conclusions:

• Bacterial imaging is a promising area for real-time tumor monitoring.
• Advancements in imaging technology and nanotechnology are expected to drive the development of novel bacterial imaging methods for tumor diagnosis.
• Further research is needed to overcome current challenges and optimize bacterial imaging for clinical application.